(Q48233485)

9 February 2018

title

Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks (English)

1 reference

9 February 2018

main subject

ventricular tachycardia

1 reference

6

1 reference

9 February 2018

author name string

T Jared Bunch

1

1 reference

9 February 2018

Srijoy Mahapatra

2

1 reference

9 February 2018

David Murdock

3

1 reference

9 February 2018

Jamie Molden

4

1 reference

9 February 2018

J Peter Weiss

5

1 reference

9 February 2018

Tami L Bair

7

1 reference

9 February 2018

Katy M Mader

8

1 reference

9 February 2018

Brian G Crandall

9

1 reference

9 February 2018

John D Day

10

1 reference

9 February 2018

Jeffrey S Osborn

11

1 reference

9 February 2018

Joseph B Muhlestein

12

1 reference

9 February 2018

Donald L Lappe

13

1 reference

9 February 2018

Jeffrey L Anderson

14

1 reference

9 February 2018

publication date

3 September 2011

1 reference

9 February 2018

Pacing and Clinical Electrophysiology

published in

1 reference

9 February 2018

volume

34

1 reference

9 February 2018

issue

12

1 reference

9 February 2018

page(s)

1600-1606

1 reference

9 February 2018

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Catheter ablation for ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

Effect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2011.03208.X

10.1111/J.1540-8159.2011.03208.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018